Kiora Stock Future Price Prediction

KPRX
 Stock
  

USD 3.64  0.09  2.41%   

Kiora Pharmaceuticals stock price prediction is an act of determining the future value of Kiora Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Kiora Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Kiora Pharmaceuticals and does not consider all of the tangible or intangible factors available from Kiora Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Kiora Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Please see Kiora Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Kiora Pharmaceuticals based on different types of headlines from major news networks to social media. The Kiora stock price prediction module provides an analysis of price elasticity to changes in media outlook on Kiora Pharmaceuticals over a specific investment horizon.
EPS Estimate Next Quarter
(4.34) 
EPS Estimate Current Year
(16.96) 
EPS Estimate Next Year
(10.92) 
Wall Street Target Price
64.5
EPS Estimate Current Quarter
(3.83) 
Using Kiora Pharmaceuticals hype-based prediction, you can estimate the value of Kiora Pharmaceuticals from the perspective of Kiora Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Kiora Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Kiora Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Kiora because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Kiora Pharmaceuticals after-hype prediction price

    
  $ 2.73  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kiora Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kiora Pharmaceuticals in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.265.2614.96
Details
Naive
Forecast
LowNext ValueHigh
0.063.0212.72
Details
1 Analysts
Consensus
LowTarget PriceHigh
5.0010.0015.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-1.47-1.33-1.19
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kiora Pharmaceuticals. Your research has to be compared to or analyzed against Kiora Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Kiora Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kiora Pharmaceuticals.

Kiora Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Kiora Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kiora Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kiora Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Kiora Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Kiora Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kiora Pharmaceuticals' historical news coverage. Kiora Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.14 and 12.43, respectively. We have considered Kiora Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 3.64
2.73
After-hype Price
12.43
Upside
Kiora Pharmaceuticals is very risky asset. Analysis and calculation of next after-hype price of Kiora Pharmaceuticals is based on 3 months time horizon.

Kiora Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Kiora Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kiora Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kiora Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.75  9.62   1.03   2.22  4 Events / Month1 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.642.7326.81 
702.19  

Kiora Pharmaceuticals Hype Timeline

Kiora Pharmaceuticals is now traded for 3.64. The entity has historical hype elasticity of -1.03 and average elasticity to hype of competition of 2.22. Kiora is projected to decline in value after the next headline with the price expected to drop to 2.73. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -26.81% whereas the daily expected return is now at -0.75%. The volatility of related hype on Kiora Pharmaceuticals is about 325.55% with expected price after next announcement by competition of 5.86. About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Kiora Pharmaceuticals was now reported as 1.38. The company recorded a loss per share of 1.44. Kiora Pharmaceuticals had not issued any dividends in recent years. The entity had 40.00 - 1.00 split on the 27th of September 2022. Given the investment horizon of 90 days the next projected press release will be in about 4 days.
Please see Kiora Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Kiora Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Kiora Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Kiora Pharmaceuticals' future price movements. Getting to know how Kiora Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kiora Pharmaceuticals may potentially react to the hype associated with one of its peers.

Kiora Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Kiora price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kiora using various technical indicators. When you analyze Kiora charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kiora Pharmaceuticals Predictive Indicators

The successful prediction of Kiora Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kiora Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kiora Pharmaceuticals based on analysis of Kiora Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kiora Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kiora Pharmaceuticals's related companies.

Story Coverage note for Kiora Pharmaceuticals

The number of cover stories for Kiora Pharmaceuticals depends on current market conditions and Kiora Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kiora Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kiora Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Kiora Pharmaceuticals Short Properties

Kiora Pharmaceuticals' future price predictability will typically decrease when Kiora Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kiora Pharmaceuticals often depends not only on the future outlook of the potential Kiora Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiora Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out8.91%
Short Percent Of Float8.93%
Float Shares652.37k
Shares Short Prior Month147.5k
Average Daily Volume Last 10 Day485.94k
Average Daily Volume In Three Month697.24k
Date Short Interest14th of October 2022
Please see Kiora Pharmaceuticals Basic Forecasting Models to cross-verify your projections. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for analysis

When running Kiora Pharmaceuticals price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.3 M
Return On Assets
(0.29) 
Return On Equity
(1.24) 
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Kiora Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.